Evaluation of the Long-term Outcome of Dorsal Ligamentoplasty Reinforced With an Internal Brace in the Treatment of Scapholunate Instability
Launched by GCS RAMSAY SANTÉ POUR L'ENSEIGNEMENT ET LA RECHERCHE · Jul 2, 2024
Trial Information
Current as of September 09, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at the long-term results of a surgery called dorsal ligamentoplasty, which is used to treat a wrist condition known as scapholunate instability. The study will follow patients who had this surgery and were fitted with an internal brace for five years after they left the hospital. The aim is to see how well this treatment works over time and if it helps improve patients' wrist function and quality of life.
To be part of this study, participants need to be at least 18 years old and have had the specific surgery mentioned. They should also be able to understand the study and agree to share their personal information. Unfortunately, individuals who have certain mental health issues or are under some form of legal protection won’t be able to participate. If you join the study, you can expect regular check-ins and assessments over the five years to monitor your wrist's recovery and function. Your participation can help provide valuable information for future treatments.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient over 18 years old who has been informed about the study and has not objected to the use of their personal data
- • Patient who has undergone dorsal ligamentoplasty reinforced with an internal brace for scapholunate instability
- Exclusion Criteria:
- • Mental deficiency or any other reason that may interfere with understanding or strict application of the protocol
- • Patient under legal protection, guardianship, or conservatorship
About Gcs Ramsay Santé Pour L'enseignement Et La Recherche
GCS Ramsay Santé pour l'Enseignement et la Recherche is a leading clinical trial sponsor dedicated to advancing healthcare through innovative research and education. As a collaborative group, it unites academic institutions and healthcare professionals to facilitate high-quality clinical trials that enhance patient care and contribute to medical knowledge. With a focus on rigorous scientific standards and ethical practices, GCS Ramsay Santé plays a crucial role in the development of new therapies and treatment protocols, ensuring that cutting-edge research translates into tangible benefits for patients and the broader community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Marseille, France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported